As the chilly winds of winter give way to the gentle warmth of spring, we find ourselves amidst a season of transformation and renewal. With each new bud and blossom, we are reminded of the potential for growth and progress in the field of neuropathy research. Please join us as we look forward to brighter […]
The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Johnson & Johnson, one of the world’s leading healthcare companies, as an esteemed 2024 Ambassador Impact Partner. This collaboration marks a significant milestone in FPN’s mission to advance research and education for individuals affected by peripheral neuropathy (PN). Collaboration for […]
February is dedicated to MMN (Multifocal Motor Neuropathy) Awareness and Rare Disease Day on February 29 – yes, it’s a Leap Year! We invite you to help us spread awareness of these important initiatives, get connected to educational opportunities, and read more about all the great research we’re funding. All this and more can be found in this month’s […]
The Foundation for Peripheral Neuropathy (FPN) is pleased to announce the 2024 Clinical Research Training Scholarship (CRTS) recipient for peripheral neuropathy (PN), Francesco E. Michelassi, MD, PhD, Neuromuscular Research Fellow, Columbia University Irving Medical Center. Michelassi’s research is fully funded by FPN and will focus on chemotherapy-induced peripheral neuropathy (CIPN), by studying how a chemotherapy […]
Read More… from Clinical Research Training Scholarship Recipient Announced
In November 2023, a new discovery was made about neuropathic pain in patients suffering from idiopathic peripheral neuropathy. Using data from the Peripheral Neuropathy Research Registry (PNRR), the Foundation for Peripheral Neuropathy’s research consortium completed an important analysis that led to an important discovery. This research is now published in a renowned research journal. Plasma […]
Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000 of these funds were spent in 2022, which resulted in over 150 new patients enrolling in the study. In 2023, an additional $24,750 was spent, […]
Read More… from FPN Funds IMAGiNe Study for anti-MAG Research
Happy New Year! For many, this is a time to reflect on successes from the past year and set intentions for the year ahead. At the Foundation, it’s no different. Our leadership is working on strategic planning, so we can be a stronger organization moving forward. No matter where you are in your PN journey, we […]
Happiest of holidays to you and yours from the Foundation for Peripheral Neuropathy. We are so grateful for your continued support in our organization, whether you already made your gift to our year end campaign, told someone about us on Giving Tuesday or recently received your PN swag. Thank you and stay safe, cozy and healthy during this season! […]
November is National Diabetes Awareness Month, a time when communities across the USA seek to bring attention to diabetes – the leading cause of peripheral neuropathy. This year’s focus from the National Institutes of Health is on taking action to prevent diabetes health problems. Check out some resources here and take control of your health. […]
The Foundation for Peripheral Neuropathy (FPN) welcomes Dr. David Bennett, MB, PhD, to the Foundation’s Scientific Advisory Board (SAB), effective November 2023. The SAB advises both the Board of Directors and staff of the Foundation on matters related to science and technology relevant to peripheral neuropathy and its research. About Dr. David Bennett Dr. David […]